On May 12, at the Ministry of Health, Prof. Dr. Tran Van Thuan – Deputy Minister of Health received 10,000 test tests for SARS-COV-2 for epidemic prevention awarded by Ampharco USA Pharmaceutical Joint Stock Company. donate.
The Ministry of Health received 10,000 Covid-19 test kits to support epidemic prevention and control. Photo: Nguyen Nhien (Office of the Ministry of Health). Faced with complicated developments in the Covid-19 epidemic since the end of April 2021 up to now, Vietnam has recorded many domestic cases in 26 provinces, cities and hospitals. The Vietnam Young Physician Association has asked the Ministry of Health to receive 10,000 SARS-COV-2 test kits produced and awarded by Ampharco USA Pharmaceutical Joint Stock Company, to support strengthening capacity for prevention and control. Covid-19 translation. At the reception, Prof. Dr. Tran Van Thuan – Deputy Minister of Health welcomed Ampharco USA Pharmaceutical Joint Stock Company used technology transferred from Military Medical Academy to research and produce the test kit. experience “made in Vietnam”. “In the face of the Covid-19 epidemic that continues to affect all aspects of socio-economic life, the fact that Ampharco USA accompanying the health sector to support 10,000 test kits is a very meaningful job, showing responsibility. Company society in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and produce products and biologicals for diagnostic testing for SARS-COV-2, actively contributing to the prevention and control of Covid- 19 ”- Deputy Minister of Health emphasized. Vice Chairman of the Board of Directors of Ampharco USA Pharmaceutical Joint Stock Company Le Ngoc Bo said that the Covid-19 test kit “AmphaBio HT- Hithroughput PCR Covid-19” is a product invested by Ampharco USA Pharmaceutical Joint Stock Company, Research and development, according to technology transferred from the Military Medical Academy, can detect most of the strains of the virus SARS-CoV-2 up to now. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven over 2,000 patient samples and is the result of more than a year of continuous efforts of the team of scientists and partners of the Company. Ampharco USA Pharmaceutical Joint Stock Company, in order to promptly respond to the Government’s policy of “anti-epidemic like anti-enemy”, contributes to Vietnam’s anti-epidemic Covid-19.
You must log in to post a comment.